Financial Information
- İntema
- Eczacıbaşı Pharmaceutical and Industrial Investment Co.
- Financial Information
- Announcements and Presentations
- Corporate Governance
- General Assembly
- Investor's Calendar
- Contact Us
- Eczacıbaşı Investment Holding Co.
- Eczacıbaşı Group Annual Report
Financial Highlights
| SUMMARIZED FINANCIAL DATA (Thousand TL) | 2020/03 | 2019/03 |
| Revenue | 268,944 | 208,272 |
| Gross Profit | 96,168 | 76,019 |
| Operating Profit | 94,426 | 70,965 |
| Depreciation and Amortisation | 5,274 | 5,352 |
| EBITDA | 99,700 | 76,317 |
| Net Income | 87,191 | -8,550 |
| 2020/03 | 2019/12 | |
| Total Assets | 5,017,914 | 4,838,337 |
| Total Shareholder's Equity | 4,364,470 | 4,277,258 |
| Total Current Assets | 1,186,136 | 1,001,345 |
| Total Current Liabilities | 391,357 | 358,554 |
| Capital Expenditures | 2,132 | 33,890 |
| Liquidity Ratios | 2020/03 | 2019/03 |
| - Current Ratio | 3.03 | 3.03 |
| - Liquidity Ratio | 2.78 | 2.81 |
| The Ratios Related to Financial Structure | 2020/03 | 2019/03 |
| - Total Liabilities / Total Assets | 0.13 | 0.13 |
| - Total Shareholders' Equity / Total Assets | 0.87 | 0.87 |
| - Total Shareholders' Equity / Total Liabilities | 6.68 | 6.92 |
| Profitability Ratios | 2020/03 | 2019/03 |
| - Net Income / Total Shareholders' Equity | 0.02 | 0.00 |
| - Net Income / Total Assets | 0.02 | 0.00 |
| - Net Income / Revenue | 0.32 | -0.04 |